Inhibition of Breast Cancer Cell Growth and Invasiveness by Dual Silencing of HER-2 and VEGF
Author:
Affiliation:
1. Division of Pharmaceutical Sciences, School of Pharmacy, University of Missouri—Kansas City, 2454 Charlotte Street, Kansas City, Missouri 64108
Publisher
American Chemical Society (ACS)
Subject
Drug Discovery,Pharmaceutical Science,Molecular Medicine
Link
https://pubs.acs.org/doi/pdf/10.1021/mp9002514
Reference61 articles.
1. Cancer Statistics, 2001
2. Gene therapy for carcinoma of the breast
3. Gene therapy for breast cancer. — review of clinical gene therapy trials for breast cancer and mdr1 gene therapy trial in cancer institute hospital
4. HER-2-Positive Breast Cancer
5. HER2-Positive Breast Cancer
Cited by 41 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A Review on Novel Applications of Nanotechnology in the Management of Prostate Cancer;Current Drug Delivery;2023-10-04
2. Bispecific Antibody-Based Immune-Cell Engagers and Their Emerging Therapeutic Targets in Cancer Immunotherapy;International Journal of Molecular Sciences;2022-05-19
3. Multi-functionalized dendrimers for targeted co-delivery of sorafenib and paclitaxel in liver cancers;Journal of Drug Delivery Science and Technology;2021-06
4. Multi-modal Multi-instance Learning Using Weakly Correlated Histopathological Images and Tabular Clinical Information;Medical Image Computing and Computer Assisted Intervention – MICCAI 2021;2021
5. Nanoparticles and prostate cancer;Nano Drug Delivery Strategies for the Treatment of Cancers;2021
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3